The Discounted Cash Flow (DCF) valuation of Phathom Pharmaceuticals Inc (PHAT) is (147.93) USD. With the latest stock price at 9.37 USD, the upside of Phathom Pharmaceuticals Inc based on DCF is -1678.8%.
Based on the latest price of 9.37 USD and our DCF valuation, Phathom Pharmaceuticals Inc (PHAT) is a sell. selling PHAT stocks now will result in a potential gain of 1678.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.1% | 6.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (799.03) - (85.69) | (147.93) |
| Upside | -8627.5% - -1014.6% | -1678.8% |